The use of implantable cardioverter-defibrillators in children

M. J. Silka, B. D. Halperin, Jack Kron

Research output: Contribution to journalArticle

Abstract

Implantable cardioverter-defibrillators have become primary therapy for most adult survivors of sudden cardiac death. However, the use of these devices in young patients who have been resuscitated from cardiovascular collapse is infrequent and requires consideration of diverse mechanisms of sudden cardiac death. The cardiovascular diseases which have been associated with sudden tachyarrhythmic death in young patients include hypertrophic and dilated cardiomyopathies, right ventricular dysplasia, long QT syndrome, idiopathic ventricular fibrillation, and congenital heart disease. Although clinical experience is limited, the prevalence of appropriate shocks in young patients who have received ICDs is approximately 50% during 2 years of follow-up. As with adults, impaired ventricular function is the strongest risk factor for sudden death after implantable cardioverter-defibrillator implantation. In this review, the clinical experience with implantable cardioverter-defibrillators (ICDs) in young patients is discussed, along with specific factors that need to be considered in this patient population. Some general recommendations regarding the use of ICDs in this population are discussed, based on the probable recurrence of a sudden arrhythmic event and outcome data for young patients after ICD implantation. The potential uses of ICDs for primary prevention of sudden cardiac death and atrial defibrillation are also discussed.

Original languageEnglish (US)
Pages (from-to)93-100
Number of pages8
JournalCardiology in Review
Volume4
Issue number2
StatePublished - 1996
Externally publishedYes

Fingerprint

Implantable Defibrillators
Sudden Cardiac Death
Sudden Death
Long QT Syndrome
Ventricular Function
Hypertrophic Cardiomyopathy
Dilated Cardiomyopathy
Primary Prevention
Population
Survivors
Heart Diseases
Shock
Cardiovascular Diseases
Recurrence
Equipment and Supplies

Keywords

  • pediatrics
  • sudden cardiac death
  • ventricular fibrillation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Silka, M. J., Halperin, B. D., & Kron, J. (1996). The use of implantable cardioverter-defibrillators in children. Cardiology in Review, 4(2), 93-100.

The use of implantable cardioverter-defibrillators in children. / Silka, M. J.; Halperin, B. D.; Kron, Jack.

In: Cardiology in Review, Vol. 4, No. 2, 1996, p. 93-100.

Research output: Contribution to journalArticle

Silka, MJ, Halperin, BD & Kron, J 1996, 'The use of implantable cardioverter-defibrillators in children', Cardiology in Review, vol. 4, no. 2, pp. 93-100.
Silka, M. J. ; Halperin, B. D. ; Kron, Jack. / The use of implantable cardioverter-defibrillators in children. In: Cardiology in Review. 1996 ; Vol. 4, No. 2. pp. 93-100.
@article{82878184aac04034b4a5bed93a04b20e,
title = "The use of implantable cardioverter-defibrillators in children",
abstract = "Implantable cardioverter-defibrillators have become primary therapy for most adult survivors of sudden cardiac death. However, the use of these devices in young patients who have been resuscitated from cardiovascular collapse is infrequent and requires consideration of diverse mechanisms of sudden cardiac death. The cardiovascular diseases which have been associated with sudden tachyarrhythmic death in young patients include hypertrophic and dilated cardiomyopathies, right ventricular dysplasia, long QT syndrome, idiopathic ventricular fibrillation, and congenital heart disease. Although clinical experience is limited, the prevalence of appropriate shocks in young patients who have received ICDs is approximately 50{\%} during 2 years of follow-up. As with adults, impaired ventricular function is the strongest risk factor for sudden death after implantable cardioverter-defibrillator implantation. In this review, the clinical experience with implantable cardioverter-defibrillators (ICDs) in young patients is discussed, along with specific factors that need to be considered in this patient population. Some general recommendations regarding the use of ICDs in this population are discussed, based on the probable recurrence of a sudden arrhythmic event and outcome data for young patients after ICD implantation. The potential uses of ICDs for primary prevention of sudden cardiac death and atrial defibrillation are also discussed.",
keywords = "pediatrics, sudden cardiac death, ventricular fibrillation",
author = "Silka, {M. J.} and Halperin, {B. D.} and Jack Kron",
year = "1996",
language = "English (US)",
volume = "4",
pages = "93--100",
journal = "Cardiology in Review",
issn = "1061-5377",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The use of implantable cardioverter-defibrillators in children

AU - Silka, M. J.

AU - Halperin, B. D.

AU - Kron, Jack

PY - 1996

Y1 - 1996

N2 - Implantable cardioverter-defibrillators have become primary therapy for most adult survivors of sudden cardiac death. However, the use of these devices in young patients who have been resuscitated from cardiovascular collapse is infrequent and requires consideration of diverse mechanisms of sudden cardiac death. The cardiovascular diseases which have been associated with sudden tachyarrhythmic death in young patients include hypertrophic and dilated cardiomyopathies, right ventricular dysplasia, long QT syndrome, idiopathic ventricular fibrillation, and congenital heart disease. Although clinical experience is limited, the prevalence of appropriate shocks in young patients who have received ICDs is approximately 50% during 2 years of follow-up. As with adults, impaired ventricular function is the strongest risk factor for sudden death after implantable cardioverter-defibrillator implantation. In this review, the clinical experience with implantable cardioverter-defibrillators (ICDs) in young patients is discussed, along with specific factors that need to be considered in this patient population. Some general recommendations regarding the use of ICDs in this population are discussed, based on the probable recurrence of a sudden arrhythmic event and outcome data for young patients after ICD implantation. The potential uses of ICDs for primary prevention of sudden cardiac death and atrial defibrillation are also discussed.

AB - Implantable cardioverter-defibrillators have become primary therapy for most adult survivors of sudden cardiac death. However, the use of these devices in young patients who have been resuscitated from cardiovascular collapse is infrequent and requires consideration of diverse mechanisms of sudden cardiac death. The cardiovascular diseases which have been associated with sudden tachyarrhythmic death in young patients include hypertrophic and dilated cardiomyopathies, right ventricular dysplasia, long QT syndrome, idiopathic ventricular fibrillation, and congenital heart disease. Although clinical experience is limited, the prevalence of appropriate shocks in young patients who have received ICDs is approximately 50% during 2 years of follow-up. As with adults, impaired ventricular function is the strongest risk factor for sudden death after implantable cardioverter-defibrillator implantation. In this review, the clinical experience with implantable cardioverter-defibrillators (ICDs) in young patients is discussed, along with specific factors that need to be considered in this patient population. Some general recommendations regarding the use of ICDs in this population are discussed, based on the probable recurrence of a sudden arrhythmic event and outcome data for young patients after ICD implantation. The potential uses of ICDs for primary prevention of sudden cardiac death and atrial defibrillation are also discussed.

KW - pediatrics

KW - sudden cardiac death

KW - ventricular fibrillation

UR - http://www.scopus.com/inward/record.url?scp=0029939136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029939136&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029939136

VL - 4

SP - 93

EP - 100

JO - Cardiology in Review

JF - Cardiology in Review

SN - 1061-5377

IS - 2

ER -